Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k ...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today introduces the new DxC 500i Clinical Analyzer*, an integrated clinical chemistry and immunoassay analyzer. As healthcare systems ...

Under an existing BNP Supply Agreement, Quidel provides Beckman Coulter with antibodies and certain other components, and Beckman Coulter acts as Quidel’s contract manufacturer for the BNP assay ...

Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up to 25 million per month by March.

Beckman, which sells test equipment to medical labs and drug companies, claims it was defrauded when Flextronics broke a contract to supply circuit boards for medical testing devices.

Beckman Coulter aims to expand its reach in accessible diagnostic tests for Alzheimer’s disease, to get ahead of potentially high demand as advancements are made in hopefully treating the ...

Danaher (DHR) said today it has agreed to acquire Beckman Coulter (BEC) for $83. 50 per share, or a total value of $6.

In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal antibody-based Alzheimer’s disease therapeutics.

Nearly two months after rumors swirled that Brea, California-based Beckman Coulter was looking at buyout offers, the company has agreed to be purchased in a deal valued at $6.8 billion. The ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announces its continuing commitment to the next generation of researchers and scientists with a call for ...

Danaher Corporation ( DHR ) on Monday said it would buy fellow medical instruments maker Beckman Coulter, Inc. ( BEC ) for $6.8 billion in cash. The.